---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-083530"
form_type: "8-K"
ticker: "PTPI"
cik: "0001815903"
company_name: "Petros Pharmaceuticals, Inc."
filed_at: "2022-07-28T23:59:59+00:00"
generated_at: "2026-06-24T07:39:19.918911+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Petros Pharmaceuticals denies fraudulent acquisition press release; reports to Nasdaq

## Summary
- A press release issued July 28, 2022 claiming an acquisition of Petros was fraudulent and not authorized by the company.
- Petros confirms it is not a party to any such acquisition and has reported the matter to Nasdaq.
- The company urges stakeholders to disregard the false press release.

## SEC filing metadata
- accession: 0001104659-22-083530
- form_type: 8-K
- ticker: PTPI
- cik: 0001815903
- company_name: Petros Pharmaceuticals, Inc.
- filed_at: 2022-07-28T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1815903/000110465922083530/0001104659-22-083530-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1815903/000110465922083530/tm2222062d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-083530
- JSON: https://secwatch.observer/filing/0001104659-22-083530.json
- Plain text: https://secwatch.observer/filing/0001104659-22-083530.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.